Evidence of Artemisinin Partial Resistance in North-Western Tanzania: Clinical and Drug Resistance Markers Study
Deus S. Ishengoma(Kampala International University), Marian Warsame(University of Gothenburg), Rashid A. Madebe(National Institute for Medical Research), Samwel Lazaro(African Malaria Network Trust), Abdallah Lusasi(African Malaria Network Trust), Issa Garimo(African Malaria Network Trust), Jovin Kitau, Jeffrey A. Bailey(John Brown University), Ally Mohamed(African Malaria Network Trust), Misago D. Seth(National Institute for Medical Research), Charlotte Rasmussen(World Health Organization), Frank Chacky(Ministry of Health, Community Development, Gender, Elderly and Children), Jonathan J. Juliano(University of North Carolina at Chapel Hill), Celine I. Mandara(National Institute for Medical Research), Abebe A. Fola(John Brown University), Ramadhan Moshi(National Institute for Medical Research), Cathrine Bakari(National Institute for Medical Research), Creyton Buguzi(National Institute for Medical Research), Sijenunu Aaron(African Malaria Network Trust), Ritha Njau(Muhimbili University of Health and Allied Sciences), Filbert Francis(National Institute for Medical Research)
Cited by 10
Related Papers
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863
A Worldwide Map of<i>Plasmodium falciparum</i>K13-Propeller Polymorphisms
|New England Journal of Medicine|2016|574
Plasmodium falciparum resistant to artemisinin and diagnostics have emerged in Ethiopia
|Nature Microbiology|2023|190
Drug-Resistance and Population Structure of Plasmodium falciparum Across the Democratic Republic of Congo Using High-Throughput Molecular Inversion Probes
|The Journal of Infectious Diseases|2018|147
Evidence of artemisinin partial resistance in northwestern Tanzania: clinical and molecular markers of resistance
|The Lancet Infectious Diseases|2024|99